Allocation was determined by investigator not involved in the assessment or intervention
This dual agonist design is what makes tirzepatide different from semaglutide and other GLP-1 only agonists
The first Phase III evidence of an overall survival signal in PROC for a checkpoint immunotherapy-based regimen was presented at the European Society for Medical Oncology Congress in October 2025
This direction will help determine safety, optimal dosing, and efficacy and capture any potential side effects and safety signals through comprehensive toxicological studies
Balanced nutrition plays a crucial role in overall health, especially when using GLP-1 medications. Because you may find yourself eating and drinking less, it's important to maximize the nutrition you're getting at each meal and snack to help avoid nutrient deficiencies that could negatively impact your health
Both act on the same GHRH receptor, so the difference is stability and duration rather than mechanism